30
Participants
Start Date
February 29, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Ketorolac Tromethamine 15 MG/ML
Single intravenous administration of Ketorolac Tromethamine injection in Cohort 1 on day 1
Ketorolac Tromethamine
Three doses of topical ketorolac tromethamine over the course of 1 day, 6 hours apart for each of 3 subsequent treatment periods in cohort 1 Three doses of Ketorolac Tromethamine, 6 hours apart, over the course of 5 days in cohorts 2 and 3
Paratus Clinical,, Blacktown
Linear Clinical Research Ltd, Nedlands
Lead Sponsor
Novilla Pharmaceuticals
INDUSTRY